183 related articles for article (PubMed ID: 3131073)
1. Effects of tumour necrosis factor on human tumour xenografts in nude mice.
Balkwill FR; Ward BG; Fiers W
Ciba Found Symp; 1987; 131():154-69. PubMed ID: 3131073
[TBL] [Abstract][Full Text] [Related]
2. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
Gridley DS; Slater JM; Stickney DR
J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
[TBL] [Abstract][Full Text] [Related]
3. Interferons alpha and gamma differ in their ability to cause tumour stasis and regression in vivo.
Balkwill FR; Griffin DB; Lee AE
Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1481-6. PubMed ID: 2512167
[TBL] [Abstract][Full Text] [Related]
4. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
[TBL] [Abstract][Full Text] [Related]
5. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons.
Balkwill FR; Lee A; Aldam G; Moodie E; Thomas JA; Tavernier J; Fiers W
Cancer Res; 1986 Aug; 46(8):3990-3. PubMed ID: 2425938
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.
Balkwill FR; Ward BG; Moodie E; Fiers W
Cancer Res; 1987 Sep; 47(18):4755-8. PubMed ID: 3113722
[TBL] [Abstract][Full Text] [Related]
7. Regression of human breast cancer xenografts in response to intralesional treatment with interferons alpha and gamma potentiated by tumor necrosis factor.
Ozzello L; de Rosa CM; Cantell K; Kauppinen HL; Habif DV
J Interferon Cytokine Res; 1995 Oct; 15(10):839-48. PubMed ID: 8564705
[TBL] [Abstract][Full Text] [Related]
8. Differential antiproliferative activities of alpha- and gamma-interferon and tumor necrosis factor alone or in combinations against two prostate cancer xenografts transplanted in nude mice.
van Moorselaar RJ; van Stratum P; Borm G; Debruyne FM; Schalken JA
Prostate; 1991; 18(4):331-44. PubMed ID: 1905403
[TBL] [Abstract][Full Text] [Related]
9. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice.
Huang P; Allam A; Perez LA; Taghian A; Freeman J; Suit HD
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):93-8. PubMed ID: 7721643
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of gamma-interferon in ascitic and solid tumor models of human ovarian cancer.
Malik ST; Knowles RG; East N; Lando D; Stamp G; Balkwill FR
Cancer Res; 1991 Dec; 51(24):6643-9. PubMed ID: 1742738
[TBL] [Abstract][Full Text] [Related]
11. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
Onishi T; Machida T; Masuda F; Iizuka N; Nakauchi K; Furuta N; Shirakawa H
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1571-8. PubMed ID: 2121869
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha in combination against human cancer transplanted into nude mice.
Naomoto Y; Tanaka N; Orita K
Acta Med Okayama; 1989 Aug; 43(4):211-21. PubMed ID: 2801185
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.
Trotta PP; Harrison SD
Cancer Res; 1987 Oct; 47(20):5347-53. PubMed ID: 3115565
[TBL] [Abstract][Full Text] [Related]
14. Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
Malik ST; East N; Boraschi D; Balkwill FR
Br J Cancer; 1992 May; 65(5):661-6. PubMed ID: 1586593
[TBL] [Abstract][Full Text] [Related]
15. Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: use of the CA125 tumour marker to predict antitumour activity.
Burbridge MF; Kraus-Berthier L; Naze M; Pierre A; Atassi G; Guilbaud N
Int J Oncol; 1999 Dec; 15(6):1155-62. PubMed ID: 10568822
[TBL] [Abstract][Full Text] [Related]
16. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical effects of tumour necrosis factor in experimental ovarian cancer.
Malik ST; Griffin DB; Fiers W; Balkwill FR
Int J Cancer; 1989 Nov; 44(5):918-25. PubMed ID: 2583871
[TBL] [Abstract][Full Text] [Related]
18. Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.
Nosoh Y; Toge T; Niimi K; Nishiyama M; Hirabayashi N; Nakanishi K; Niimoto M; Hattori T
Jpn J Surg; 1987 May; 17(3):168-73. PubMed ID: 3114530
[TBL] [Abstract][Full Text] [Related]
19. Treatment of human breast cancer xenografts using natural interferons-alpha and -gamma injected singly or in combination.
Ozzello L; Habif DV; De Rosa CM; Cantell K
J Interferon Res; 1988 Oct; 8(5):679-90. PubMed ID: 3148672
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.
Beniers AJ; van Moorselaar RJ; Peelen WP; Debruyne FM; Schalken JA
Urol Res; 1991; 19(2):91-8. PubMed ID: 1906659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
